Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
David Henry MD
David Henry MD Advisory Board
Sara Tolaney MD, MPH
Sara M. Tolaney MD, MPH Advisory Board
Eric Jonasch MD
Eric Jonasch MD Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · June 21, 2022

Avelumab Plus Trabectedin for Advanced Liposarcoma and Leiomyosarcoma

Clinical Cancer Research

 

 Save  Recommend
 Share

Additional Info

Clinical Cancer Research
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma
Clin. Cancer Res 2022 Jun 01;28(11)2306-2312, MJ Wagner, Y Zhang, LD Cranmer, ET Loggers, G Black, S McDonnell, S Maxwell, R Johnson, R Moore, P Hermida de Viveiros, L Aicher, KS Smythe, Q He, RL Jones, SM Pollack

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated